210 related articles for article (PubMed ID: 9581564)
21. Recombinant human lactoferrin-Fc fusion with an improved plasma half-life.
Shiga Y; Oshima Y; Kojima Y; Sugimoto A; Tamaki N; Murata D; Takeuchi T; Sato A
Eur J Pharm Sci; 2015 Jan; 67():136-143. PubMed ID: 25433245
[TBL] [Abstract][Full Text] [Related]
22. Characterization of recombinant human lactoferrin secreted in milk of transgenic mice.
Nuijens JH; van Berkel PH; Geerts ME; Hartevelt PP; de Boer HA; van Veen HA; Pieper FR
J Biol Chem; 1997 Mar; 272(13):8802-7. PubMed ID: 9079716
[TBL] [Abstract][Full Text] [Related]
23. Specific binding of lactoferrin to Aeromonas hydrophila.
Kishore AR; Erdei J; Naidu SS; Falsen E; Forsgren A; Naidu AS
FEMS Microbiol Lett; 1991 Sep; 67(1):115-9. PubMed ID: 1778417
[TBL] [Abstract][Full Text] [Related]
24. Lactoferrin, a Critical Player in Neonate Intestinal Development: RHLF may be a Good Choice in Formula.
Wang W; Cheng Z; Wang X; An Q; Huang K; Dai Y; Meng Q; Zhang Y
J Agric Food Chem; 2021 Aug; 69(31):8726-8736. PubMed ID: 34323077
[TBL] [Abstract][Full Text] [Related]
25. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line.
Bi BY; Liu JL; Legrand D; Roche AC; Capron M; Spik G; Mazurier J
Eur J Cell Biol; 1996 Mar; 69(3):288-96. PubMed ID: 8900493
[TBL] [Abstract][Full Text] [Related]
26. Lactoferrin-binding proteins in Shigella flexneri.
Tigyi Z; Kishore AR; Maeland JA; Forsgren A; Naidu AS
Infect Immun; 1992 Jul; 60(7):2619-26. PubMed ID: 1319403
[TBL] [Abstract][Full Text] [Related]
27. Differential glycosylation of rhLf expressed in the mammary gland of transgenic mice.
Zhao C; Liu Z; Fan B; Dai Y; Wang L; Zheng M; Wang M; Niu H; Xi F; Li N; Zhang D
Anim Biotechnol; 2006; 17(1):13-20. PubMed ID: 16621756
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human lactoferrin and iron transport across Caco-2 monolayers: effect of heat treatment on the binding to cells.
Conesa C; Pocoví C; Pérez MD; Calvo M; Sánchez L
J Agric Food Chem; 2008 Apr; 56(8):2831-7. PubMed ID: 18355020
[TBL] [Abstract][Full Text] [Related]
29. Role of basic residues of human lactoferrin in the interaction with B lymphocytes.
Kawasaki Y; Sato K; Shinmoto H; Dosako S
Biosci Biotechnol Biochem; 2000 Feb; 64(2):314-8. PubMed ID: 10737187
[TBL] [Abstract][Full Text] [Related]
30. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells.
Legrand D; Vigié K; Said EA; Elass E; Masson M; Slomianny MC; Carpentier M; Briand JP; Mazurier J; Hovanessian AG
Eur J Biochem; 2004 Jan; 271(2):303-17. PubMed ID: 14717698
[TBL] [Abstract][Full Text] [Related]
31. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
32. Interaction of human lactoferrin with the rat liver.
Debanne MT; Regoeczi E; Sweeney GD; Krestynski F
Am J Physiol; 1985 Apr; 248(4 Pt 1):G463-9. PubMed ID: 2984944
[TBL] [Abstract][Full Text] [Related]
33. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.
Kruzel ML; Actor JK; Zimecki M; Wise J; Płoszaj P; Mirza S; Kruzel M; Hwang SA; Ba X; Boldogh I
J Biotechnol; 2013 Dec; 168(4):666-75. PubMed ID: 24070904
[TBL] [Abstract][Full Text] [Related]
34. Large scale production of recombinant human lactoferrin in the milk of transgenic cows.
van Berkel PH; Welling MM; Geerts M; van Veen HA; Ravensbergen B; Salaheddine M; Pauwels EK; Pieper F; Nuijens JH; Nibbering PH
Nat Biotechnol; 2002 May; 20(5):484-7. PubMed ID: 11981562
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of bovine lactoferrin as a glycyrrhizin-binding protein in vitro.
Tanigawa K; Fujihara M; Furuya T; Shimoyama Y; Morishima N; Ohtsuki K
Biol Pharm Bull; 2000 Apr; 23(4):438-42. PubMed ID: 10784423
[TBL] [Abstract][Full Text] [Related]
36. Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation.
Hyvönen P; Suojala L; Haaranen J; von Wright A; Pyörälä S
Biotechnol J; 2006 Apr; 1(4):410-2. PubMed ID: 16892268
[TBL] [Abstract][Full Text] [Related]
37. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding.
Ziere GJ; Bijsterbosch MK; van Berkel TJ
J Biol Chem; 1993 Dec; 268(36):27069-75. PubMed ID: 7903302
[TBL] [Abstract][Full Text] [Related]
38. "Dilysine trigger" in transferrins probed by mutagenesis of lactoferrin: crystal structures of the R210G, R210E, and R210L mutants of human lactoferrin.
Peterson NA; Arcus VL; Anderson BF; Tweedie JW; Jameson GB; Baker EN
Biochemistry; 2002 Dec; 41(48):14167-75. PubMed ID: 12450380
[TBL] [Abstract][Full Text] [Related]
39. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line.
Damiens E; El Yazidi I; Mazurier J; Elass-Rochard E; Duthille I; Spik G; Boilly-Marer Y
Eur J Cell Biol; 1998 Dec; 77(4):344-51. PubMed ID: 9930659
[TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of recombinant human lactoferrin in edible alga Chlamydomonas reinhardtii.
Pang X; Tong Y; Xue W; Yang YF; Chen X; Liu J; Chen D
Biosci Biotechnol Biochem; 2019 May; 83(5):851-859. PubMed ID: 30669954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
